John F. Harris
Co-Founder and Managing Partner @ Jazz Venture Partners
Seattle, United States
John F. Harris is a Series A investor at Jazz Venture Partners in Seattle focused on Health Care and Dental. John Harris is the Co-Founder and Managing Partner at JAZZ Venture Partners. He attended Stanford University and the Finance Department - Kellogg School of Management.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 60%
Last updated:
For AI agents: llms.txt
Industries John F. Harris invests in
Stages John F. Harris invests in
Countries John F. Harris invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 2 (40%)
- Dental 1 (20%)
- Internet 1 (20%)
- Robotics 1 (20%)
- Software 1 (20%)
Stage
- Series A 3 (60%)
- Series B 2 (40%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Cadence Neuroscience
|
Cadence Neuroscience is an early-stage company developing new medical device therapies for the treatment of epilepsy, central pain, and other neurological disorders. The company's core technology has been developed at Mayo Clinic and is under clinical evaluation. Its medical device therapies provide medical practitioners with the procedurethat can be used to tailor brain stimulation therapy to each individual and enhance seizure control compared to currently used protocols.Cadence Neuroscience was established in 2017 and is headquartered in Redmond, Washington. | $26M / Series B / Feb 28, 2023 | |
KLOWEN Braces
|
KLOWEN Braces offers braces system that uses prefabricated, modular brackets to straighten teeth, faster, better, and more comfortable than conventional braces. It was established in 2019 and is based in Fort Collins, Colorado, United States. | $10.5M / Series A / May 20, 2022 | |
|
Cadence Neuroscience
|
Cadence Neuroscience is an early-stage company developing new medical device therapies for the treatment of epilepsy, central pain, and other neurological disorders. The company's core technology has been developed at Mayo Clinic and is under clinical evaluation. Its medical device therapies provide medical practitioners with the procedurethat can be used to tailor brain stimulation therapy to each individual and enhance seizure control compared to currently used protocols.Cadence Neuroscience was established in 2017 and is headquartered in Redmond, Washington. | $15M / Series A / Oct 11, 2019 | |
Perceptive Automata
|
Perceptive Automata is solving what is often described as the hardest of the hard problems for automated driving: human behavior prediction technology for the safe large-scale rollout of highly automated (L2/3) and autonomous (L4/5) vehicles, especially in urban areas.The company enables those vehicles to understand what people might donext so they can navigate safely and smoothly around humans, including pedestrians, cyclists, and other drivers. The level of understanding of our human-like AI goes well beyond what standard physics-based approaches can deliver, including information that can’t be gained any other way.Importantly, in addition to increased safety, we enable a much more natural and smooth human-like driving of L4/5 autonomous vehicles. This is essential for autonomous vehicles to be accepted into a human-dominated road environment and also by passengers of robotaxi services. Without this capability autonomous vehicles simply will not function well enough.Perceptive Automata is working with OEMs, suppliers, and tech companies that are building or integrating ADAS and autonomous driving systems.The team is comprised of Harvard, MIT, and Stanford neuroscientists and AI experts working out of offices in Boston and Silicon Valley. | $16M / Series A / Oct 09, 2018 | |
Aira
|
Called a Godsend by The New York Times, Aira is on a mission to make the world accessible anywhere, anytime. They provide on-remand, remote visual interpretation services for the blind and low vision community. Download the app, press a button and your phone's camera streams a live video to one our highly screened Visual Interpreters. | $12M / Series B / May 16, 2017 |
Co-Investors
About Jazz Venture Partners
JAZZ Venture Partners is the leading venture capital firm focused on technologies that extend the boundaries of human performance. They invest in companies at the intersection of digital technology and neuroscience. They are interested in companies that leverage cutting-edge brain science to inform powerful technology platforms that are impactingthe human experience, such as virtual and augmented reality, immersive video gaming, artificial intelligence, and closed-loop human-computer systems. Their portfolio companies are unlocking human potential in important markets: health, mind-body wellness, peak mental and physical performance, accelerated learning and training, sports, and entertainment.The partners are proven investors, entrepreneurs, neuroscientists, and technologists. They have deep domain experience and unparalleled access to innovative companies, talent, and strategic resources. Their multidisciplinary backgrounds allow us to meaningfully support exceptional entrepreneurs and executives in building category-defining companies.
Jazz Venture Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
John F. Harris
Co-Founder and Managing Partner
|
|||
|
John F. Harris
Co-Founder and Managing Partner
|
|||
John Spinale
Co-Founder, Managing Partner
|
|||
Zack Lynch
Co-founder, General Partner
|
|||
Adam Gazzaley
Co-Founder & Chief Scientist
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does John F. Harris invest in?
John F. Harris invests primarily in Health Care, Dental and Internet startups, most often at Series A and Series B stage. Most of the 5 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact John F. Harris?
Public channels for John F. Harris include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did John F. Harris last invest?
The most recent investment recorded for John F. Harris closed in Feb 2023. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
